FogPharma Stock

fogpharma.comHealthcareFounded: 2016Funding to Date: $361.63MM

FogPharma is a biotechnology company developing cell-penetrating miniproteins (CPMPs) that combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules.

Register for Details

For more details on financing and valuation for FogPharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for FogPharma.

Register Today

Team

Management Team

Weiqing Zhou
Co-Founder & Chief Operating Officer
David Lane Ph.D
Co-Founder
Milenko Cicmil Ph.D
Vice President, Translational Biology
Howard Stern
Chief Scientific Officer
Michael Hale Ph.D
Vice President, Chemistry
John McGee Ph.D
Executive
Gerard Hilinski Ph.D
Co-Founder & Senior Scientist
Gregory Verdine Ph.D
Co-Founder, President, Chief Scientific Officer, Chief Executive Officer & Chairman

Board Members

Gregory Verdine Ph.D
Krishna Yeshwant MD
GV
Barbara Weber MD
Jeffrey Leerink
SVB Leerink
Richard Klausner MD
Edward Fitzgerald
Lianyong Chen Ph.D
6 Dimensions Capital

Other companies like FogPharma in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

FogPharma has netted a $178 Million Series D financing to develop Helicon polypeptide therapeutics against hard targets.
/PRNewswire/ -- FogPharma today announced the appointment of Fang Wang, Ph.D., as Vice President of Biology and Nancy Wilker, Ph.D., J.D., as Vice President...